Health condition · Clinically reviewed
Haemochromatosis, iron overload that is treatable when caught early.
Common, inherited and widely under-diagnosed. Iron studies, HFE testing and regular venesection prevent almost every complication if started before the liver, heart and pancreas are damaged.
Why trust this guide
- 01
Clinically reviewed
Written by our editorial team and reviewed by a UK hepatologist and haematologist before publication.
- 02
Sourced from guidance
Aligned with NICE, BSH and EASL guidance, and referenced at the end of the page.
- 03
Current for 2026
Reflects modern practice including HFE genetic testing, MRI iron quantification and BSH venesection standards.
Key facts
Haemochromatosis at a glance.
The essentials, in plain English. What it is, the main genetic and secondary forms, and how it is diagnosed and treated in the UK today.
-
What it is
Iron overload from excessive iron absorption or transfusion. Untreated, iron deposits in the liver, heart, pancreas and joints.
-
Hereditary type 1
HFE-related (C282Y homozygote most common), autosomal recessive. Common but under-diagnosed, up to 1 in 200 Northern Europeans.
-
Other genetic forms
Type 2 juvenile (HJV, HAMP), type 3 (TfR2) and type 4 ferroportin disease (autosomal dominant), all managed by specialists.
-
Secondary causes
Transfusion-dependent anaemia (thalassaemia, sickle cell, MDS), chronic liver disease, chronic alcohol excess and excess iron supplementation.
-
First-line tests
Transferrin saturation over 45 percent in men or 40 percent in women plus a raised ferritin is the trigger for HFE genetic testing.
-
First-line treatment
Regular venesection to reduce iron, then lifelong maintenance. Chelation is reserved for selected transfusion-dependent patients.
Why this guide matters
A treatable disease, if caught in time.
Iron overload is silent for years, then damages the liver, heart and pancreas together. The three ideas below shape the rest of this page.
-
Iron studies come first
Fasting transferrin saturation and ferritin will pick up almost every case worth investigating, long before symptoms mature.
-
Venesection is the treatment
Regularly removing blood empties iron stores. Started early enough, it prevents cirrhosis, cardiomyopathy and diabetes.
-
Family screening saves relatives
HFE testing of first-degree relatives is one of the most cost-effective genetic interventions in UK medicine.
How the diagnosis is made
From suspicion to a confirmed plan.
The steps a UK GP, hepatologist and haematologist will normally follow, so you know what to expect and why each stage matters.
Phase 1 · Assessing
Symptoms, iron studies and secondary causes
Phase 2 · Confirming
HFE testing, liver, cardiac and endocrine review
Phase 3 · Planning
MDT care and family screening
- 01
Assessing
Clinical suspicion
Fatigue, joint pain (especially the second and third knuckles), abnormal liver tests, diabetes, skin bronzing or a family history should prompt iron studies.
- 02
Assessing
Transferrin saturation and ferritin
Fasting transferrin saturation over 45 percent in men or 40 percent in women plus a raised ferritin is the classic first-line pattern.
- 03
Assessing
Rule out secondary causes
Assess alcohol intake, chronic liver disease, inflammation and any transfusion or supplement history that can raise ferritin without true overload.
- 04
Confirming
HFE genetic testing
Confirms hereditary haemochromatosis. C282Y homozygotes and selected compound heterozygotes require formal iron-overload assessment.
- 05
Confirming
Liver assessment
LFTs, FibroScan (see /treatments/fibroscan-clinic/) and MRI-PDFF or T2* imaging (see /treatments/mri-liver-iron-quantification/) to stage fibrosis and quantify hepatic iron.
- 06
Confirming
Cardiac and endocrine workup
Echocardiogram and cardiac MRI T2* for iron cardiomyopathy, HbA1c for diabetes, and pituitary, thyroid and gonadal hormones for endocrine involvement.
- 07
Planning
Specialist MDT and family screening
Hepatology, haematology and clinical genetics coordinate care. First-degree relatives are offered cascade HFE testing.
Typical timeline: iron studies and HFE testing within weeks, MDT plan within a few months.
Symptoms
What haemochromatosis feels like.
Presentation is insidious, so the first clue is often a raised ferritin on a routine blood test. When symptoms appear, they cluster across several organ systems.
-
Fatigue and lethargy
The most common early symptom, often long-standing before iron studies are requested.
-
Joint pain
A characteristic arthropathy of the second and third metacarpophalangeal joints, wrists, hips and knees.
-
Skin bronzing
Slate-grey or bronze pigmentation, especially on sun-exposed skin, from combined iron and melanin deposition.
-
Liver disease
Abnormal LFTs, hepatomegaly and, if untreated, cirrhosis with a heightened risk of hepatocellular carcinoma.
-
Bronze diabetes
Pancreatic iron deposition impairs insulin secretion, giving the classic combination of diabetes and pigmentation.
-
Hypogonadism and endocrine change
Low libido, erectile dysfunction, menstrual disturbance, hypothyroidism and hypopituitarism from iron in endocrine tissues.
-
Cardiac symptoms
Iron cardiomyopathy causes breathlessness, heart failure and arrhythmia (see /conditions/heart-failure/).
-
Asymptomatic screening pickup
Many patients are identified through routine ferritin, incidental imaging or family cascade screening long before symptoms.
Treatment
How haemochromatosis is treated in the UK.
Venesection first for the great majority, chelation for selected transfusion-dependent patients, and organ-specific care through a hepatology-haematology-genetics MDT.
-
Therapeutic venesection
The first-line treatment. Weekly removal of around 500 mL of blood until ferritin falls below 50 micrograms per litre, then maintenance every two to three months.
-
Maintenance monitoring
Lifelong follow-up of ferritin, transferrin saturation, LFTs and end-organ function to keep iron in the target range.
-
Iron chelation
Deferasirox, deferoxamine or deferiprone for selected patients who cannot tolerate venesection or who have transfusion-dependent iron overload. Specialist-commissioned.
-
Diet and lifestyle
Avoid iron and vitamin C supplements, limit red meat, avoid raw shellfish and minimise alcohol, which acts synergistically with iron on the liver.
-
HCC surveillance
Six-monthly ultrasound in patients with cirrhosis, as haemochromatosis meaningfully increases hepatocellular carcinoma risk (see /conditions/hepatocellular-carcinoma/).
-
Organ-specific care
Diabetes, cardiac, hypogonadism (including testosterone replacement) and thyroid or pituitary support delivered through the relevant specialists.
-
Family cascade screening
First-degree relatives are offered HFE genotyping and iron studies through clinical genetics to detect disease before end-organ damage.
-
Liver transplantation
Considered in decompensated cirrhosis or hepatocellular carcinoma meeting UK criteria (see /treatments/liver-transplant-clinic/).
What this guide is based on
The sources behind every claim on this page.
UK national guidance and international specialist standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
Your GP or specialist knows your history and iron studies, and can tell you which parts apply to you. If in doubt, get seen.
-
NICE Clinical Knowledge Summary. Haemochromatosis.
-
British Society for Haematology (BSH). Guidelines on the diagnosis and therapy of genetic haemochromatosis.
-
European Association for the Study of the Liver (EASL). Clinical practice guidelines on haemochromatosis.
-
Haemochromatosis UK. Patient information and support standards.
Red flags
When haemochromatosis needs urgent attention.
Most people do well on venesection. These are the situations that need faster, specialist input.
-
Decompensated liver disease
Jaundice, ascites, variceal bleeding or encephalopathy require urgent hepatology review and transplant assessment.
-
Suspected hepatocellular carcinoma
New liver lesion, rising alpha-fetoprotein or weight loss in a patient with cirrhosis needs prompt imaging and MDT review.
-
Cardiac symptoms
Breathlessness, palpitations, syncope or ankle swelling raise the possibility of iron cardiomyopathy or arrhythmia and should be assessed urgently.
-
New diabetes with pigmentation
The combination of new diabetes and skin bronzing warrants immediate iron studies to exclude advanced haemochromatosis.
-
Very high ferritin
Ferritin above 1000 micrograms per litre with a raised transferrin saturation raises the risk of fibrosis and warrants specialist referral.
-
Severe joint disease
Rapidly progressive arthropathy or joint destruction needs rheumatology input alongside iron control.
-
Pregnancy and family planning
Genetic counselling is offered to affected patients and their partners to inform reproductive choices and cascade screening.
-
Chelation side effects
Renal, hepatic, ocular or auditory changes on chelation therapy should be reported to the specialist team promptly.
-
Infections after venesection
Rarely, iron overload increases susceptibility to certain infections. Fever and rigors should be assessed without delay.
Living with it
A lifelong condition, with predictable rhythms.
Four practical priorities that shape day to day life: keeping to venesection, sensible food and drink choices, cascade family testing and reporting new symptoms early.
A quiet reminder
Steady iron control does the heavy lifting.
Regular venesection over years is more powerful than any short-term intervention. Consistency is the treatment.
- 01 Routine
Keep to your venesection schedule
Regular blood removal is the single most effective thing you can do to prevent long-term complications.
- 02 Diet
Sensible food and drink choices
Avoid iron and vitamin C supplements, limit red meat and raw shellfish, and keep alcohol low, as it amplifies liver injury.
- 03 Family
Talk to your relatives
First-degree relatives can be offered HFE testing through their GP or clinical genetics, catching disease before damage occurs.
- 04 Escalate
Report new symptoms early
New breathlessness, jaundice, weight loss or worsening joint pain deserves an early conversation with your specialist team.
Frequently asked
Everything we get asked about haemochromatosis.
Quick answers on iron studies, HFE testing, venesection, diet and family screening.
-
What is haemochromatosis?
Haemochromatosis is a condition of iron overload. In the hereditary form, faulty regulation of iron absorption (most often through the HFE gene) allows iron to accumulate in the liver, heart, pancreas, joints and endocrine organs. Secondary forms follow transfusion, chronic liver disease or excessive iron intake.
-
How common is hereditary haemochromatosis in the UK?
It is one of the most common inherited disorders in people of Northern European ancestry, with up to 1 in 200 being C282Y homozygotes. However, only a proportion develop clinically significant iron overload, and the condition is widely under-diagnosed.
-
What tests confirm the diagnosis?
Fasting transferrin saturation and ferritin are the first-line tests. If iron studies are raised, HFE genetic testing is performed, alongside liver assessment with FibroScan and MRI iron quantification, and cardiac and endocrine work-up where indicated.
-
How is haemochromatosis treated?
Regular therapeutic venesection is the mainstay: usually weekly removal of around 500 mL of blood until ferritin falls below 50 micrograms per litre, followed by lifelong maintenance every two to three months. Iron chelation is reserved for selected patients.
-
Do I need to change my diet?
Yes, but the changes are practical rather than extreme. Avoid iron and vitamin C supplements, limit red meat and raw shellfish, and keep alcohol low. A balanced diet with dairy and tea (which reduce iron absorption) can help.
-
Should my family be tested?
First-degree relatives of a person with hereditary haemochromatosis should be offered iron studies and HFE genetic testing, typically through their GP or a clinical genetics service. Detecting the condition before end-organ damage is one of the strongest reasons for cascade screening.
Related content
Keep reading.
-
Chronic liver disease
How chronic damage progresses to cirrhosis.
Learn more -
Hepatocellular carcinoma
Liver cancer risk in cirrhosis and iron overload.
Learn more -
Hepatic encephalopathy
Brain effects of advanced liver disease.
Learn more -
Cirrhosis
Scarring of the liver and its complications.
Learn more -
Autoimmune hepatitis
Related chronic liver condition.
Learn more -
FibroScan clinic
Non-invasive assessment of liver stiffness.
Learn more -
MRI liver iron quantification
MRI-PDFF and T2* for hepatic iron measurement.
Learn more -
Liver transplant clinic
Assessment for decompensated liver disease.
Learn more -
Private MRI scan
Rapid access diagnostic imaging.
Learn more -
Whole exome sequencing
Broad genetic testing when HFE is not diagnostic.
Learn more -
Hereditary cancer panel
Non-BRCA hereditary cancer risk assessment.
Learn more -
All conditions
Browse every clinical guide.
Learn more